Nadim Ahmed - 18 Oct 2021 Form 3 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role: President and CEO, Director
Signature: /s/ Jeffrey Trigilio, attorney-in-fact
Issuer symbol: CGEM
Transactions as of: 18 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 20 Oct 2021, 16:33:24 UTC
Next filing: 07 Mar 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney